Table 1.

Baseline characteristics of NERD patients receiving Esoxx or placebo, combined with PPIs

	Esoxx (n = 76)	Placebo (n = 78)	P value
Female, N (%)	48 (63.2%)	46 (59.0%)	NS
Age (years), mean ± s.d.	45.45 ± 14.98	45.51 ± 13.37	NS
Range (min–max)	18–81	24–75
BMI (kg/m2)	23.87 ± 3.10	23.77 ± 3.23	NS
GERD total symptom score	7.30 ± 2.4	7.19 ± 2.6	NS
Proportion of patients with ≥3 GERD symptoms (%)	44.0	41.0	NS
Heartburn	84.2	85.9
Retrosternal pain	53.9	49.3
Acid regurgitation	69.7	66.2
Acid taste in the mouth	60.5	59.2
Past treatment with PPIs (%)	56.6	64.8	NS
Past treatment with other anti‐GERD therapies (%)	23.7	29.6	NS